INTERCEPT PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2012 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Intercept Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2012 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 2, 2023 was 41.8M shares, a 0.99% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 41.8M +409K +0.99% Nov 2, 2023 10-Q 2023-11-06
Q2 2023 41.8M +12M +40.2% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 41.7M +12M +40.3% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 41.7M +12M +40.3% Jan 31, 2023 10-K 2023-03-02
Q3 2022 41.4M +11.9M +40.2% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 29.8M -3.4M -10.3% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 29.7M -3.45M -10.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 29.7M -3.32M -10.1% Jan 31, 2022 10-K 2022-03-02
Q3 2021 29.5M -3.45M -10.4% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 33.2M +220K +0.67% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 33.2M +217K +0.66% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 33M +163K +0.5% Dec 31, 2020 10-K 2021-02-25
Q3 2020 33M +259K +0.79% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 33M +284K +0.87% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 32.9M +3.16M +10.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 32.9M +3.16M +10.6% Dec 31, 2019 10-K 2020-02-25
Q3 2019 32.7M +3.08M +10.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 32.7M +3.13M +10.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 29.8M +4.45M +17.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 29.7M +4.52M +18% Dec 31, 2018 10-K 2019-03-01
Q3 2018 29.7M +4.55M +18.1% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 29.6M +4.46M +17.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 25.3M +323K +1.29% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 25.2M +341K +1.37% Dec 31, 2017 10-K 2018-02-28
Q3 2017 25.1M +293K +1.18% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 25.1M +374K +1.51% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 25M +414K +1.68% Apr 28, 2017 10-Q 2017-05-10
Q4 2016 24.8M +425K +1.74% Jan 31, 2017 10-K 2017-03-01
Q3 2016 24.8M +477K +1.96% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 24.7M +524K +2.17% Jul 31, 2016 10-Q 2016-08-09
Q1 2016 24.6M +523K +2.17% Apr 15, 2016 10-Q 2016-05-10
Q4 2015 24.4M Jan 31, 2016 10-K 2016-02-29
Q3 2015 24.3M +2.97M +13.9% Oct 31, 2015 10-Q 2015-11-09
Q2 2015 24.2M +2.98M +14.1% Jul 15, 2015 10-Q 2015-08-07
Q1 2015 24.1M +2.98M +14.2% Apr 30, 2015 10-Q 2015-05-11
Q3 2014 21.4M +2.02M +10.5% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 21.2M +2.04M +10.6% Jul 31, 2014 10-Q 2014-08-11
Q1 2014 21.1M +4.47M +26.9% Apr 30, 2014 10-Q 2014-05-09
Q3 2013 19.3M +2.82M +17.1% Oct 31, 2013 10-Q 2013-11-14
Q2 2013 19.2M Aug 1, 2013 10-Q 2013-08-13
Q1 2013 16.6M Mar 15, 2013 10-K 2013-04-01
Q3 2012 16.5M Nov 12, 2012 10-Q/A 2012-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.